D
David Ginsburg
Researcher at University of Michigan
Publications - 277
Citations - 20935
David Ginsburg is an academic researcher from University of Michigan. The author has contributed to research in topics: Von Willebrand factor & Gene. The author has an hindex of 76, co-authored 266 publications receiving 19779 citations. Previous affiliations of David Ginsburg include Parke-Davis & Life Sciences Institute.
Papers
More filters
Journal ArticleDOI
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Gallia Levy,William C. Nichols,Eric C.-Y. Lian,Tatiana Foroud,Jeanette N. McClintick,Beth McGee,Angela Y. Yang,David R. Siemieniak,Kenneth R. Stark,Ralph A. Gruppo,Ravindra Sarode,Susan B. Shurin,Visalam Chandrasekaran,Sally P. Stabler,Hernan Sabio,Eric E. Bouhassira,Jefferson D. Upshaw,David Ginsburg,Han-Mou Tsai +18 more
TL;DR: In this article, the ADAMTS family of zinc metalloproteinase genes (ADAMTS13) was identified as the molecular mechanism responsible for TTP, and it was shown that the deficiency of ADADTS13 is the molecular mechanisms responsible for the development of TTP.
Journal ArticleDOI
Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
Daniel T. Eitzman,Ronald D. McCoy,Xianxian Zheng,William P. Fay,Tingliang Shen,David Ginsburg,Richard Simon +6 more
TL;DR: Data demonstrate a direct correlation between the genetically determined level of PAI-1 expression and the extent of collagen accumulation that follows inflammatory lung injury and strongly support the hypothesis that alterations in fibrinolytic activity influenceThe extent of pulmonary fibrosis that occurs after inflammatory injury.
Journal ArticleDOI
Detectable clonal mosaicism from birth to old age and its relationship to cancer.
Cathy C. Laurie,Cecelia A. Laurie,Kenneth Rice,Kimberly F. Doheny,Leila R. Zelnick,Caitlin P. McHugh,Hua Ling,Kurt N. Hetrick,Elizabeth W. Pugh,Christopher I. Amos,Qingyi Wei,Li-E Wang,Jeffrey E. Lee,Kathleen C. Barnes,Nadia N. Hansel,Rasika A. Mathias,Denise Daley,Terri H. Beaty,Alan F. Scott,Ingo Ruczinski,Robert B. Scharpf,Laura J. Bierut,Sarah M. Hartz,Maria Teresa Landi,Neal D. Freedman,Lynn R. Goldin,David Ginsburg,Jun-Jun Li,Karl C. Desch,Sara S. Strom,William J. Blot,Lisa B. Signorello,Sue A. Ingles,Stephen J. Chanock,Sonja I. Berndt,Loic Le Marchand,Brian E. Henderson,Kristine R. Monroe,John A. Heit,Mariza de Andrade,Sebastian M. Armasu,Cynthia Regnier,William L. Lowe,M. Geoffrey Hayes,Mary L. Marazita,Eleanor Feingold,Jeffrey C. Murray,Mads Melbye,Bjarke Feenstra,Jae H. Kang,Janey L. Wiggs,Gail P. Jarvik,Andrew McDavid,Venkatraman E. Seshan,Daniel B. Mirel,Andrew Crenshaw,Nataliya Sharopova,Anastasia L. Wise,Jess Shen,David R. Crosslin,David M. Levine,Xiuwen Zheng,Jenna Udren,Siiri N. Bennett,Sarah C. Nelson,Stephanie M. Gogarten,Matthew P. Conomos,Patrick J. Heagerty,Teri A. Manolio,Louis R. Pasquale,Christopher A. Haiman,Neil E. Caporaso,Bruce S. Weir +72 more
TL;DR: Clonal mosaicism for large chromosomal anomalies (duplications, deletions and uniparental disomy) is detected using SNP microarray data from over 50,000 subjects recruited for genome-wide association studies to identify common deleted regions with genes previously associated with hematological cancers.
Journal ArticleDOI
Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS)
Gregory E. Crawford,Ingeborg Holt,James R R Whittle,Bryn D. Webb,Denise Tai,Sean Davis,Elliott H. Margulies,Yi Chen,John A. Bernat,David Ginsburg,Daixing Zhou,Shujun Luo,Thomas J. Vasicek,Mark J. Daly,Tyra G. Wolfsberg,Francis S. Collins +15 more
TL;DR: High-throughput analysis, using massively parallel signature sequencing (MPSS), of 230,000 tags from a DNase library generated from quiescent human CD4+ T cells identifies 14,190 clusters of sequences that group within close proximity to each other that represent valid DNase HS sites.
Journal ArticleDOI
Impact, Diagnosis and Treatment of von Willebrand Disease*
J E Sadler,P. M. Mannucci,Erik Berntorp,Nikolay P. Bochkov,Victor Boulyjenkov,David Ginsburg,Dominique Meyer,Ian R. Peake,Francesco Rodeghiero,Arun Srivastava +9 more
TL;DR: There are at least 580,000 persons with symptomatic VWD worldwide who could benefit from appropriate diagnosis followed by replacement or pharmacological therapy, and 80% of these persons live in the developing world.